We are live on ! Find out more
Lazard Asset Management

Lazard Asset Management Portfolio holdings

AUM $60.8B
1-Year Est. Return 22.47%
This Fund
S&P 500
This Quarter Est. Return
+0.1%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+302.07%
AUM
$68.4B
AUM Growth
-$6.42B
Cap. Flow
-$9.95B
Cap. Flow %
-14.55%
Top 10 Hldgs %
25.74%
Holding
2,605
New
281
Increased
825
Reduced
894
Closed
234

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$433M
2
MRK icon
Merck
MRK
+$286M
3
J icon
Jacobs Solutions
J
+$265M
4
EFX icon
Equifax
EFX
+$253M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$240M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$710M
2
JNJ icon
Johnson & Johnson
JNJ
+$574M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$480M
4
MRVL icon
Marvell Technology
MRVL
+$377M
5
WFC icon
Wells Fargo
WFC
+$333M

Sector Composition

Rank Sector Weight
1 Technology 26.04%
2 Financials 14.64%
3 Healthcare 12%
4 Industrials 10.54%
5 Consumer Discretionary 9.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AVA icon
2101
Avista
AVA
$3.22B
– –
-29
Closed -$1K
AVNW icon
2102
Aviat Networks
AVNW
$273M
– –
-24,108
Closed -$521K
AVPT icon
2103
AvePoint
AVPT
$2.85B
– –
-97
Closed -$1K
AZTA icon
2104
Azenta
AZTA
$1.4B
– –
-13,912
Closed -$673K
AZZ icon
2105
AZZ Inc
AZZ
$4.64B
– –
-1,074
Closed -$88K
BASE
2106
DELISTED
Couchbase
BASE
– –
-62
Closed –
BBAI icon
2107
BigBear.ai
BBAI
$1.44B
– –
-218,742
Closed -$319K
BBIO icon
2108
BridgeBio Pharma
BBIO
$16B
– –
-38
Closed –
BBUC
2109
Brookfield Business Corp Class A Subordinate Voting Shares
BBUC
$6.29B
– –
-51
Closed -$1K
BEAM icon
2110
Beam Therapeutics
BEAM
$2.81B
$0 ﹤0.01%
24
-54,551
-100% -$1.39M
BGC icon
2111
BGC Group
BGC
$5.23B
– –
-27,778
Closed -$255K
BGSF icon
2112
BGSF Inc
BGSF
$59.8M
– –
-156
Closed -$1K
BKE icon
2113
Buckle
BKE
$2.36B
– –
-20,440
Closed -$898K
BLUE
2114
DELISTED
bluebird bio
BLUE
$0 ﹤0.01%
17
-1
-6% -$9
BNED icon
2115
Barnes & Noble Education
BNED
$438M
– –
-92
Closed –
BNTX icon
2116
BioNTech
BNTX
$23.1B
$0 ﹤0.01%
7
– –
BTBT icon
2117
Bit Digital
BTBT
$485M
$0 ﹤0.01%
329
-123
-27% -$483
BUR icon
2118
Burford Capital
BUR
$931M
– –
-2,462
Closed -$32K
BWEN icon
2119
Broadwind
BWEN
$109M
– –
-535
Closed -$1K
BBBY
2120
Bed Bath & Beyond
BBBY
$441M
– –
-9
Closed –
BZH icon
2121
Beazer Homes USA
BZH
$934M
– –
-11,919
Closed -$405K
CAAP icon
2122
Corporacion America
CAAP
$4.26B
– –
-1,608
Closed -$28K
CABA icon
2123
Cabaletta Bio
CABA
$455M
$0 ﹤0.01%
57
– –
CAN
2124
Canaan Creative
CAN
$142M
$0 ﹤0.01%
400
– –
CAPR icon
2125
Capricor Therapeutics
CAPR
$236M
$0 ﹤0.01%
69
– –
83 84
85
86 87

Similar funds

Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Aviva
Aviva London, United Kingdom $59.6B AUM 28.44% 1-Year Est. Return
Mitsubishi UFJ Financial Group
Mitsubishi UFJ Financial Group Tokyo, Japan $62.1B AUM 41.06% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Lazard Asset Management's Q4 2024 Portfolio in Review

As of Q4 2024, Lazard Asset Management held 2,605 positions worth $68.4B, down 8.6% from $74.8B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Lazard Asset Management withdrew a net $9.95B in Q4 2024, closing 234 positions and reducing 894 holdings. Its most notable exit was Atlantica Sustainable Infrastructure plc Ordinary Shares, an estimated $210M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Lazard Asset Management opened a new position in Vaxcyte worth $39.8M.

  • Lazard Asset Management's largest Q4 2024 buy was Vaxcyte: 486,764 shares worth $39.8M.
  • Lazard Asset Management added most to Eli Lilly in Q4 2024, an estimated $433M increase.
  • Lazard Asset Management's biggest Q4 2024 reduction was Microsoft, cutting an estimated $710M.
  • Lazard Asset Management fully exited Atlantica Sustainable Infrastructure plc Ordinary Shares in Q4 2024, selling an estimated $210M.
  • Lazard Asset Management's ten largest holdings make up 26% of its $68.4B portfolio in Q4 2024.
  • Lazard Asset Management opened 281 new positions and closed 234 in Q4 2024.
  • Lazard Asset Management's portfolio value fell 8.6% quarter-over-quarter to $68.4B.

Based on Lazard Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.